Detalles de la búsqueda
1.
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.
Cancer Immunol Immunother
; 72(5): 1233-1246, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385211
2.
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
Cancer Immunol Immunother
; 71(3): 613-625, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282497
3.
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
J Korean Med Sci
; 37(1): e2, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981678
4.
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.
Cancer Immunol Immunother
; 70(1): 31-45, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623477
5.
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Br J Haematol
; 189(2): 303-312, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012231
6.
Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.
Blood
; 132(15): 1604-1613, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108064
7.
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
BMC Cancer
; 20(1): 803, 2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32831058
8.
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas.
Ann Hematol
; 99(1): 83-91, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807859
9.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Nature
; 506(7488): 328-33, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24522528
10.
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.
Blood
; 129(1): 38-47, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733357
11.
18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System.
Eur J Nucl Med Mol Imaging
; 46(1): 107-115, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187105
12.
Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma.
BMC Cancer
; 19(1): 59, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642286
13.
Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
Ann Hematol
; 98(5): 1135-1147, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30758645
14.
Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
BMC Cancer
; 18(1): 729, 2018 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29986691
15.
Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.
Ann Hematol
; 97(6): 955-965, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500710
16.
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts.
Ann Hematol
; 97(12): 2309-2317, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30073392
17.
l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3 -induced myeloid differentiation in acute myeloid leukemia cells.
Int J Cancer
; 140(10): 2364-2374, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224619
18.
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(1): 61-70, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26234722
19.
5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.
Mol Carcinog
; 55(5): 611-21, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25788004
20.
Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.
J Transl Med
; 14: 82, 2016 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009330